Company intelligence / Profile preview

EnGen Bio

San Francisco, California, USAengenbio.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

EnGen Bio has achieved an important preclinical milestone with its universal Type A influenza vaccine candidate. The company is optimizing a recombinantly manufactured, lyophilized, room temperature-stable subunit vaccine that targets a novel epitope on the flu virus’s M1 matrix protein. This approach aims to elicit long-lasting and broadly neutralizing antibody responses in both humans and animals. No clinical trial results are available yet as programs remain preclinical.

Therapeutic areas: Infectious Diseases
Modalities: Recombinant subunit vaccinesTherapeutic antibodies
Industry: Biotech

Drug pipeline

1 asset

Universal Subunit Vaccine (flu prevention)

Preclinical

Partnerships

Not explicitly listed; however, the company notes interest from major funders such as NIH, Department of Defense, Department of Agriculture, and Bill & Melinda Gates Foundation for grants in this area.

Beyond the preview

Go deeper on EnGen Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnGen Bio.